[HTML][HTML] Prediction and prevention of the first episode of overt hepatic encephalopathy in patients with cirrhosis

SJ Gairing, EM Schleicher, PR Galle… - Hepatology …, 2023 - journals.lww.com
Hepatic encephalopathy (HE) is one of the most important complications of patients with
liver cirrhosis. In addition, HE is associated with a dismal prognosis and has detrimental …

Diabetes mellitus–risk factor and potential future target for hepatic encephalopathy in patients with liver cirrhosis?

SJ Gairing, EM Schleicher, C Labenz - Metabolic brain disease, 2023 - Springer
Hepatic encephalopathy (HE) is one of the major complications of cirrhosis, and its presence
is associated with poor survival. Several risk factors for HE are well established, including …

[HTML][HTML] Predicting overt hepatic encephalopathy after TIPS: Value of three minimal hepatic encephalopathy tests

AF Ehrenbauer, H Schneider, L Stockhoff, A Tiede… - JHEP Reports, 2023 - Elsevier
Background & Aims Hepatic encephalopathy (HE) is a frequent and severe complication in
patients after transjugular intrahepatic portosystemic shunt (TIPS) insertion. However, risk …

The causality between gut microbiome and liver cirrhosis: a bi-directional two-sample Mendelian randomization analysis

QA Xiao, YF Yang, L Chen, YC Xie, HT Li… - Frontiers in …, 2023 - frontiersin.org
Background and aim Previous studies have reported an association between gut microbiota
and cirrhosis. However, the causality between intestinal flora and liver cirrhosis still remains …

[HTML][HTML] Hepatic encephalopathy post-TIPS: current status and prospects in predictive assessment

X Xu, Y Yang, X Tan, Z Zhang, B Wang, X Yang… - Computational and …, 2024 - Elsevier
Transjugular intrahepatic portosystemic shunt (TIPS) is an essential procedure for the
treatment of portal hypertension but can result in hepatic encephalopathy (HE), a serious …

Rifaximin alfa and liver diseases: more than a treatment for encephalopathy, a disease modifier

A Torre, J Córdova-Gallardo… - … and Clinical Risk …, 2023 - Taylor & Francis
RFX, a rifamycin-based antibacterial agent obtained by the culture of the actinomycete
Streptomyces mediterranei, has a broad antibacterial spectrum covering gram-positive …

Cerebral Aspects of Portal Hypertension: Hepatic Encephalopathy

KL Thomsen, M Sørensen, K Kjærgaard… - Clinics in Liver …, 2024 - liver.theclinics.com
Portal hypertension comes for a cause, whether prehepatic, intrahepatic, or posthepatic. By
far, the most frequent cause is intrahepatic in the form of liver cirrhosis that besides portal …

[HTML][HTML] Contemporary concepts of prevention and management of gastroesophageal variceal bleeding in liver cirrhosis patients

DV Garbuzenko - World Journal of Hepatology, 2024 - ncbi.nlm.nih.gov
This editorial describes the contemporary concepts of prevention and management of
gastroesophageal variceal bleeding in liver cirrhosis (LC) patients according to the current …

Value of systemic inflammation markers for the detection of minimal and prediction of overt hepatic encephalopathy after TIPS insertion

A Tiede, L Stockhoff, AF Ehrenbauer, H Rieland… - Metabolic Brain …, 2025 - Springer
Abstract Development of overt hepatic encephalopathy (oHE) is a particularly feared
complication when considering treatment with transjugular intrahepatic portosystemic shunt …

[HTML][HTML] Sarcopenia and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review

L Abenavoli, M Statsenko, GGM Scarlata, D Morano… - Livers, 2024 - mdpi.com
The primary objective of modern medicine is to extend human life expectancy. Currently, the
majority of hospital patients across various clinical settings are elderly or advanced-age …